Login / Signup

High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome.

Nithya KrishnamurthyDaisuke NishizakiScott M LippmanHirotaka MiyashitaMary K NeslineSarabjot PablaJeffrey M ConroyPaul DePietroShumei KatoRazelle Kurzrock
Published in: Therapeutic advances in medical oncology (2024)
High CTLA-4, especially when combined with high PD-L1 transcript expression, was a significant positive predictive biomarker for better outcomes (PFS and OS) in patients on immunotherapy.
Keyphrases
  • poor prognosis
  • end stage renal disease
  • ejection fraction
  • binding protein
  • long non coding rna
  • rna seq
  • peritoneal dialysis
  • adipose tissue
  • weight loss